Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Current Issue

July 2022 (Vol. 42 Issue 7) Table of Contents
Anticancer Research: 42 (7)

Issue highlights

  • Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art
  • High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer
  • Long Non-coding RNAs Sponging MicroRNAs With Efficacy in Preclinical In Vivo Models of Esophageal Squamous Cell Cancer
  • Intradural Extramedullary Spinal Metastases from Non-neurogenic Primary Tumors: A Systematic Review
  • Immunotherapy for Non-small Cell Lung Cancer: Current Agents and Potential Molecular Targets


Special Issue of ANTICANCER RESEARCH

on NEW ANTICANCER AGENTS

Topics:

A. Experimental studies on “Νew Anticancer Agents”

1. Synthesis and evaluation in vitro and in vivo
2. Mechanism of action
3. Reversal of resistance to anticancer agents
4. Oncolytic viruses

B. Clinical studies on “New Anticancer Agents”

1. Pharmacology
2. Clinical trials
3. Combination chemotherapy
4. Immunotherapeutic agents
5. New methodologies in drug delivery
6. Vaccines

Publication date: March 2, 2023; Submission deadline: December 30, 2022

Instructions for the preparation and submission of reviews and original articles.


Special Issue of ANTICANCER RESEARCH

on PROSTATE CANCER

Topics:

  • New diagnostic procedures
  • Genetic polymorphisms
  • Environmental and dietary risk factors
  • Chemoprevention
  • Treatment of early prostate cancer
  • Treatment of metastatic prostate cancer
  • Advances in surgical procedures
  • New drugs and drug combinations
  • Radiotherapy
  • Immunotherapy
  • Benign prostate hyperplasia

The aim of this special issue is to cover all aspects of the current advances in the experimental and clinical research on prostate cancer.

Publication date: January 5, 2023; Submission deadline: October 30, 2022

Instructions for the preparation and submission of reviews and original articles.


Featured Articles

  • Patient-derived Orthotopic Xenograft (PDOX) Nude Mouse Model of Soft-tissue Sarcoma More Closely...
    February 09, 2015
  • Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and...
    September 25, 2015
  • The Effect of Various Doses of Oral Vitamin D3 Supplementation on Gut Microbiota in...
    December 31, 2019
  • Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a...
    December 30, 2014
  • Curcumin and Epigallocatechin Gallate Inhibit the Cancer Stem Cell Phenotype via Down-...
    December 30, 2014
  • A Long Noncoding RNA, lncRNA-ATB, Is Involved in the Progression and Prognosis of Colorectal Cancer
    March 06, 2015

Latest Articles

  • You have access
    Up-regulation of CPNE1 Appears to Enhance Cancer Progression in HER2-positive and Luminal A Breast Cancer Cells
    HYE YOUNG CHOI, HYO JUNG LEE, KYOUNG MI MOON, DONG KYU MOON, SECHAN LEE, HYEWON PARK, JINPYO HONG, MI JUNG PARK, DONG KYUN WOO and JAE CHEAL YOO
    Anticancer Research July 2022, 42 (7) 3445-3452; DOI: https://doi.org/10.21873/anticanres.15831
  • You have access
    Influence of Dose Reduction of Prophylactic Dexamethasone on Chemotherapy-induced Nausea and Anorexia in Patients Under 55 Years Old Treated With Anthracycline-containing Regimens
    YOSHITAKA SAITO, YOH TAKEKUMA, TAKASHI TAKESHITA and MITSURU SUGAWARA
    Anticancer Research July 2022, 42 (7) 3753-3758; DOI: https://doi.org/10.21873/anticanres.15865
  • Open Access
    Impact of Dose-Volume Parameters of Parotid Glands on Xerostomia in Patients Irradiated for Head-and-Neck Cancer
    DIRK RADES, BRITTA WARWAS, FLORIAN CREMERS, KARSTEN GERULL, CHRISTIAN IDEL, KARL L. BRUCHHAGE, SAMER G. HAKIM and STEVEN E. SCHILD
    Anticancer Research July 2022, 42 (7) 3551-3556; DOI: https://doi.org/10.21873/anticanres.15841
  • You have access
    Antibody-immunotoxin Conjugate Using FcBP-mediated Photoconjugation to Treat Cancer
    KWANG-HYEOK KIM, JISOO PARK, JIN-OCK KIM, HAN-JIK KO and SANG GYU PARK
    Anticancer Research July 2022, 42 (7) 3453-3461; DOI: https://doi.org/10.21873/anticanres.15832
  • You have access
    Impact of Older Age and Medico-social Factors on the Decision to Offer Adjuvant Chemotherapy to Patients With Breast Cancer
    KUMI NIGUMA, KANAKO MAMISHIN, YOICHI NAITO, SHOGO NOMURA, MASASHI WAKABAYASHI, SHOTA KUSUHARA, CHIKAKO FUNASAKA, TAKEHIRO NAKAO, YOKO FUKASAWA, CHIHIRO KONDOH, KENICHI HARANO, TAKAHIRO KOGAWA, NOBUAKI MATSUBARA, AKO HOSONO, TATSUYA ONISHI, TOSHIKATSU KAWASAKI and TORU MUKOHARA
    Anticancer Research July 2022, 42 (7) 3743-3751; DOI: https://doi.org/10.21873/anticanres.15864
  • You have access
    Independent Validation of a Risk Stratification Model Predicting Survival in Patients With Metastatic Hormone-sensitive Prostate Cancer
    CARSTEN NIEDER and LUKA STANISAVLJEVIC
    Anticancer Research July 2022, 42 (7) 3675-3679; DOI: https://doi.org/10.21873/anticanres.15856
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention

Visit the official website of Anticancer Research.
Back to top
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire